Skip to content
Clinical Trials for Alzheimer's Disease

New Haven, Connecticut

Alzheimer's disease clinical trials in New Haven, CT

8 Alzheimer's disease studies are recruiting participants at sites in New Haven as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

New Haven at a glance

  • 8 studies are recruiting at a site in New Haven.
  • By phase: Phase 1 (1), Phase 2 (1), Phase 2/3 (2), Phase 3 (2), No phase (2). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (5), industry (3).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in New Haven

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Yale University
    Registry record
    NCT07177352 · updated
  2. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Yale University, Alzheimer's Disease Research Unit ( Site 1059)
    Registry record
    NCT07033494 · updated
  3. Music for Pain and Dementia

    • No phase
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Study site
    Connecticut Mental Health Clinic
    Registry record
    NCT07602283 · updated
  4. Exploring the Utility of [18F]3F4AP for Demyelination Imaging

    • Phase 1
    • Ages 18 to 90
    • All sexes
    Sponsor
    Yale University
    Study site
    Yale University PET Center
    Registry record
    NCT06999434 · updated
  5. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    Yale University School of Medicine - Section of Cardiology
    Registry record
    NCT06563895 · updated
  6. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Yale University School of Medicine
    Registry record
    NCT05552157 · updated
  7. A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Yale University School of Medicine
    Registry record
    NCT06647498 · updated
  8. Evaluation of a Mobile App Program for Coping With Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Yale University
    Study site
    Smilow Cancer Hospital
    Registry record
    NCT06923501 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in New Haven, CT on ClinicalTrials.gov.

Ask about studies near New Haven

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call